Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1104-1118
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1104
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1104
Table 1 KIF 23 expression in gastric cancer and normal tissues, n (%)
Cases | KIF23 expression | P value | ||
Low | High | |||
Cancer | 174 | 30 (17.2) | 144 (82.8) | < 0.001 |
Normal | 174 | 169 (97.1) | 5 (2.9) |
Table 2 Correlation between KIF23 expression and clinicopathological features in gastric cancer
n = 174 | KIF23 expression | P value | ||
Low (n = 130) | High (n = 44) | |||
Age (yr) | 0.539 | |||
≤ 60 | 90 | 69 | 21 | |
> 60 | 84 | 61 | 23 | |
Gender | 0.583 | |||
Male | 129 | 95 | 34 | |
Female | 45 | 35 | 10 | |
Diameter (cm) | 0.667 | |||
≤ 4 | 80 | 61 | 19 | |
> 4 | 94 | 69 | 25 | |
Differentiation type | 0.188 | |||
Poor | 104 | 74 | 30 | |
Non-poor | 70 | 56 | 14 | |
Borrmann type | 0.453 | |||
I-II | 15 | 10 | 5 | |
III-IV | 159 | 120 | 39 | |
T stage | 0.051 | |||
T1-T3 | 56 | 47 | 9 | |
T4 | 118 | 83 | 35 | |
N stage | 0.0471 | |||
N0 | 61 | 51 | 10 | |
N1-N3 | 113 | 79 | 34 | |
TNM stage | 0.0221 | |||
I-IIA | 37 | 33 | 4 | |
IIB-IIIC | 137 | 97 | 40 |
Table 3 Prognostic factors in Cox’s proportional hazards model in gastric cancer (n = 174)
Variable | Univariate | Multivariate | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Age (yr): > 60 vs ≤ 60 | 0.822 | 0.555-1.217 | 0.328 | |||
Gender: Male vs female | 1.297 | 0.838-2.008 | 0.243 | |||
Diameter: > 4 cm vs ≤ 4 cm | 0.616 | 0.350-1.084 | 0.093 | |||
Differentiation type: Poor vs non-poor | 0.552 | 0.336-0.906 | 0.0191 | 0.840 | 0.502-1.404 | 0.505 |
Borrmann type: I-IV | 1.703 | 1.109-2.617 | 0.0151 | 1.410 | 0.916-2.169 | 0.119 |
T stage: T1-T4 | 1.546 | 1.141-2.095 | 0.0051 | 1.310 | 0.858-2.000 | 0.210 |
N stage: N0-N3 | 1.693 | 1.424-2.013 | 0.0001 | 1.869 | 1.356-2.575 | 0.0001 |
TNM stage: I-IIIC | 2.410 | 1.637-3.547 | 0.0001 | 0.595 | 0.259-1.366 | 0.221 |
KIF23 expression: High-level vs low-level | 1.064 | 1.006-1.126 | 0.0291 | 1.069 | 1.006-1.135 | 0.0301 |
Table 4 Correlation between KIF23 mRNA expression and gastric cancer patients in Kaplan–Meier database
Variable | Cases | HR (95%CI) | P value |
Overall patients | 593 | 1.64 (1.32-2.02) | 3.9e-061 |
T stage | |||
T2 | 66 | 2.05 (0.98-4.26) | 0.0501 |
T3 | 117 | 1.83 (1.14-2.94) | 0.0121 |
N stage | |||
N0 | 38 | 2.78 (0.88-8.73) | 0.069 |
N1 + N2 + N3 | 175 | 1.33 (0.92-1.94) | 0.130 |
M stage | |||
M0 | 186 | 1.74 (1.17-2.59) | 0.00531 |
M1 | 31 | 0.49 (0.19-1.23) | 0.120 |
Gender | |||
Male | 360 | 2.07 (1.60-2.69) | 1.9e-081 |
Female | 138 | 1.50 (0.95-2.37) | 0.078 |
Differentiation | |||
Well | 32 | 0.41 (0.16-1.08) | 0.062 |
Moderate | 67 | 0.75 (0.38-1.48) | 0.400 |
Poor | 165 | 1.67 (1.12-2.49) | 0.0121 |
Lauren classification | |||
GITA | 179 | 0.76 (0.52-1.11) | 0.15 |
GDA | 106 | 2.05 (1.23-3.39) | 0.00471 |
GMA | 25 | 0.22 (0.03-1.68) | 0.11 |
- Citation: Liang WT, Liu XF, Huang HB, Gao ZM, Li K. Prognostic significance of KIF23 expression in gastric cancer. World J Gastrointest Oncol 2020; 12(10): 1104-1118
- URL: https://www.wjgnet.com/1948-5204/full/v12/i10/1104.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i10.1104